Published in Clin Cancer Res on June 01, 1999
Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol (2001) 3.44
CYP24A1 inhibition enhances the antitumor activity of calcitriol. Endocrinology (2010) 1.04
Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia. Int J Cancer (2006) 1.02
Vitamin D in combination cancer treatment. J Cancer (2010) 0.96
Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system. Cell Cycle (2010) 0.94
1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models. Cancer (2010) 0.92
A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors. Cancer Chemother Pharmacol (2009) 0.89
What is the role of vitamin D in autism? Dermatoendocrinol (2013) 0.89
Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer model. BMC Cancer (2013) 0.88
Transcriptional effects of 1,25 dihydroxyvitamin D(3) physiological and supra-physiological concentrations in breast cancer organotypic culture. BMC Cancer (2013) 0.84
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors. Cancer Chemother Pharmacol (2008) 0.84
Vitamin D and cancer: clinical aspects. Best Pract Res Clin Endocrinol Metab (2011) 0.83
A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors. Invest New Drugs (2010) 0.81
Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies. Invest New Drugs (2003) 0.81
Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes. Horm Cancer (2013) 0.81
Perspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogs. Front Oncol (2014) 0.81
Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment. Oncotarget (2015) 0.80
Importance of apical membrane delivery of 1,25-dihydroxyvitamin D3 to vitamin D-responsive gene expression in the colon. Am J Physiol Gastrointest Liver Physiol (2012) 0.79
Rationale for the development and current status of calcitriol in androgen-independent prostate cancer. World J Urol (2005) 0.78
Vitamin D Analogs Potentiate the Antitumor Effect of Imatinib Mesylate in a Human A549 Lung Tumor Model. Int J Mol Sci (2015) 0.78
A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol (2013) 0.78
Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic Interactions. J Cancer (2016) 0.77
Targeted delivery of 1,25-dihydroxyvitamin D3 to colon tissue and identification of a major 1,25-dihydroxyvitamin D3 glycoside from Solanumglaucophyllum plant leaves. J Steroid Biochem Mol Biol (2014) 0.77
Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer. Cancer Prev Res (Phila) (2015) 0.76
PKPD modelling to predict altered disposition of 1α,25-dihydroxyvitamin D3 in mice due to dose-dependent regulation of CYP27B1 on synthesis and CYP24A1 on degradation. Br J Pharmacol (2015) 0.75
A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer. J Oncol Pharm Pract (2014) 0.75
26,26,26,27,27,27-Hexadeuterated-1,25-Dihydroxyvitamin D3 (1,25D-d6) As Adjuvant of Chemotherapy in Breast Cancer Cell Lines. Cancers (Basel) (2013) 0.75
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol (1999) 9.22
Evaluation of a clinical medical librarianship program at a university Health Sciences Library. Bull Med Libr Assoc (1976) 4.59
Mucosal inflammation in asthma. Am Rev Respir Dis (1990) 4.11
Hypersensitivity reactions from taxol. J Clin Oncol (1990) 3.83
Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J (1993) 3.75
Optimal testing parameters for blood cultures. Clin Infect Dis (2004) 3.17
Reduced bone density in cystic fibrosis: DeltaF508 mutation is an independent risk factor. Eur Respir J (2005) 2.48
Neuropsychological status at seizure onset in children: risk factors for early cognitive deficits. Neurology (2009) 2.46
Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis (1990) 2.45
Increased vascularity of the bronchial mucosa in mild asthma. Am J Respir Crit Care Med (1997) 2.25
Submental intubation: a literature review. Int J Oral Maxillofac Surg (2011) 2.21
Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst (1994) 2.05
Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax (1999) 1.94
Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res (1988) 1.84
Treatment or prevention of pulmonary cellular damage with pharmacologic doses of corticosteroid. Surg Gynecol Obstet (1972) 1.79
Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells (1997) 1.78
An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol (1993) 1.76
Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis (1992) 1.75
Metastatic carcinoma involving the testis. Clinical and pathologic distinction from primary testicular neoplasms. Cancer (1984) 1.71
Gastric Neurectomy for Gastric and Duodenal Ulceration : An Anatomic and Clinical Study. Ann Surg (1947) 1.71
Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. Clin Nephrol (2004) 1.70
Measurement of the energy spectrum of cosmic-ray induced neutrons aboard an ER-2 high-altitude airplane. Nucl Instrum Methods Phys Res A (2002) 1.64
Cutaneous involvement in malignant histiocytosis. Case report and review of the literature. Arch Dermatol (1981) 1.64
An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med (1999) 1.51
Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol (1993) 1.50
Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis. Thorax (2007) 1.50
The safety aspects of fiberoptic bronchoscopy, bronchoalveolar lavage, and endobronchial biopsy in asthma. Am Rev Respir Dis (1991) 1.49
Natural transfer of viable microbes in space. Icarus (2000) 1.45
Clinical features and natural history of intramedullary spinal cord metastasis. Cancer (1985) 1.43
Determination of intermediate biomarker expression levels by quantitative reverse transcription-polymerase chain reaction in oral mucosa of cancer patients treated with liarozole. Clin Cancer Res (2000) 1.40
Cystotomy closure. A comparison of the strength of appositional and inverting suture patterns. Vet Surg (1990) 1.40
Evidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous dermatoses. Br J Dermatol (2014) 1.40
Challenges in pulmonary fibrosis: 7--Novel therapies and lung transplantation. Thorax (2008) 1.40
Transient stress lymphocytosis during crisis of sickle cell anemia and emergency trauma and medical conditions. An immunophenotyping study. Arch Pathol Lab Med (1990) 1.39
Histologic evaluation of response to implantation of polyvinilidine plates in dogs and rats. Vet Surg (1989) 1.39
Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. Clin Cancer Res (2001) 1.35
Vascular occlusion in sickle cell disease: current concepts and unanswered questions. Blood (1991) 1.35
Space radiation cancer risks and uncertainties for Mars missions. Radiat Res (2001) 1.33
1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res (1999) 1.27
Behavior problems in children at time of first recognized seizure and changes over the following 3 years. Epilepsy Behav (2011) 1.27
Photon correlation spectroscopy of hemoglobin: diffusion of oxy-HbA and oxy-HbS. Biopolymers (1978) 1.25
Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Urology (1997) 1.24
Development of B-lymphocyte colony-forming cells in foetal mouse tissues. Immunology (1976) 1.22
Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res (1997) 1.20
Human tumor models in the severe combined immune deficient (scid) mouse. Cancer Chemother Pharmacol (1997) 1.20
Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J (1992) 1.20
Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem (2001) 1.19
Formation and alignment of Z lines in living chick myotubes microinjected with rhodamine-labeled alpha-actinin. J Cell Biol (1986) 1.19
The iron superoxide dismutase of Legionella pneumophila is essential for viability. J Bacteriol (1994) 1.18
Importance of continued testicular suppression in hormone-refractory prostate cancer. J Clin Oncol (1993) 1.18
Inherited elevation of alkaline phosphatase activity in the absence of disease. N Engl J Med (1979) 1.15
High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol (1992) 1.15
Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism (2001) 1.15
Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Clin Cancer Res (2001) 1.15
Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest (1991) 1.15
Phase I study of vinblastine and verapamil given by concurrent iv infusion. Cancer Treat Rep (1985) 1.15
Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol (1999) 1.14
The nature of the cells generating B-lymphocyte colonies in vitro. J Cell Physiol (1976) 1.14
Acquired extrinsic pulmonic stenosis caused by mediastinal tumors. Cancer (1982) 1.13
Pulmonary injury secondary to extracorporeal circulation. An ultrastructural study. J Thorac Cardiovasc Surg (1973) 1.11
Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma. Clin Cancer Res (2000) 1.11
Pregelation aggregation of sickle cell hemoglobin. Proc Natl Acad Sci U S A (1974) 1.11
Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors. Proc Natl Acad Sci U S A (1998) 1.09
Pulmonary microcirculatory response to shock, transfusion, and pump-oxygenator procedures: a unified mechanism underlying pulmonary damage. Surgery (1968) 1.09
Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res (2001) 1.09
Myocardial infarction in sickle cell disease. J Natl Med Assoc (1996) 1.08
Taxol: a history of pharmaceutical development and current pharmaceutical concerns. J Natl Cancer Inst Monogr (1993) 1.07
Sickle cell anemia: does myocardial ischemia occur during crisis? J Natl Med Assoc (1991) 1.07
Dysfunction of the detrusor and urethra in multiple sclerosis: the role of drug therapy. Can J Surg (1982) 1.07
Factors influencing options in primary breast cancer treatment. J Clin Oncol (1987) 1.07
Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Br J Pharmacol (1994) 1.06
Unusual acid-fast bacteria in panniculitis. Arch Dermatol (1966) 1.06
Accurate universal parameterization of absorption cross sections III--light systems. Nucl Instrum Methods Phys Res B (1999) 1.06
Ceramide stimulates epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells. Evidence that ceramide may mediate sphingosine action. J Biol Chem (1991) 1.05
The lung in hemorrhagic shock. II. Observations on alveolar and vascular ultrastructure. Am J Pathol (1970) 1.05
A Study of the Results, both Favorable and Unfavorable, of Section of the Vagus Nerves in the Treatment of Peptic Ulcer. Ann Surg (1947) 1.05
Hypercalcemia and neuroendocrine carcinoma of the prostate: a report of three cases and a review of the literature. J Clin Oncol (1992) 1.05
Mechanical properties of oxygenated red blood cells in sickle cell (HbSS) disease. Blood (1984) 1.04
Beta 2-adrenoceptor agonist-mediated inhibition of human airway smooth muscle cell proliferation: importance of the duration of beta 2-adrenoceptor stimulation. Br J Pharmacol (1997) 1.04
A phase II study of taxol in patients with malignant melanoma. Invest New Drugs (1991) 1.04
Bromide intoxication. Johns Hopkins Med J (1976) 1.04
4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone: a prejunctional dopamine receptor agonist. J Med Chem (1985) 1.03
Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels. Biochem Pharmacol (1995) 1.03
Pathological spectrum of liver diseases in sickle cell disease. Dig Dis Sci (1986) 1.03
Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J Clin Nutr (1997) 1.03
The lung in hemorrhagic shock. I. In vivo observations of pulmonary microcirculation in cats. Am J Pathol (1970) 1.02
Perceived social support among depressed elderly, middle-aged, and young-adult samples: cross-sectional and longitudinal analyses. J Affect Disord (1999) 1.02
The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase. J Clin Endocrinol Metab (1982) 1.01
Liver involvement in sickle cell disease. Medicine (Baltimore) (1985) 1.00
Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment. Urol Clin North Am (1992) 1.00
Prevention of lower respiratory herpes simplex virus infection with acyclovir in patients with the adult respiratory distress syndrome. Am Rev Respir Dis (1987) 1.00
Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med (2001) 1.00
Bone regeneration within a human segmental mandible defect: a preliminary report. Am J Otolaryngol (1995) 1.00